Header Logo

Connection

JOHN KNIGHT to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications JOHN KNIGHT has written about Drug Evaluation, Preclinical.
JOHN KNIGHT
Connection Strength
0.142
Drug Evaluation, Preclinical
  1. Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease. J Biol Chem. 2018 06 29; 293(26):10026-10040.
    View in: PubMed
    Score: 0.142
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.